AZD-7762

DB12242InvestigationalSmall molecule

AZD7762 has been investigated for the treatment of Cancer, Solid Tumors, and Advanced Solid Malignancies.

Mechanism: Pharmacologically active on Serine/threonine-protein kinase Chk1
Curator reviewed
Formula / weight: C₁₇H₁₉FN₄O₂S · 362.422 g/mol (avg)
Code names: AZD-7762

Resolves to

Compound

Structure

InChIKeyIAYGCINLNONXHY-LBPRGKRZSA-NSMILESNC(=O)NC1=C(SC(=C1)C1=CC=CC(F)=C1)C(=O)N[C@H]1CCCNC1

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

3Clinical trialsPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with AZD-7762, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.